3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pain, Postoperative
2
Pain
2
Ovarian Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Agnosia
2
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Lymphoma
1
Kidney Neoplasms
1
Ileus
1
Head and Neck Neoplasms
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Curative Breast Cancer Surgery
1
Constipation
1
Colonic Neoplasms
1
Chronic Pain
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Female
1
Acute Pain
1
Interventions
Tamoxifen
4
Exercise
3
pyrotinib
2
abemaciclib
2
Paclitaxel
2
Metformin
2
Letrozole
2
Cyclophosphamide
2
Control Groups
2
Capecitabine
2
Bupivacaine
2
Aromatase Inhibitors
2
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
palbociclib
1
iniparib
1
exemestane
1
durvalumab
1
darolutamide
1
Yoga
1
Waiting Lists
1
Vitamin D
1
Tretinoin
1
Trastuzumab
1
Tocopherols
1
Thioctic Acid
1
Standard of Care
1
Sodium Chloride
1
Self-Help Groups
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Breast Cancer Female
×
Ketorolac Tromethamine
×
Clear all
NCT03007381
2017-08-16
KANGAROO
Nova Scotia Health Authority
Phase 4
Withdrawn